Condition: Advanced Breast Cancer · Sponsor: TerSera Therapeutics LLC
The primary objective of this trial is to evaluate ovarian suppression following treatment with ZOLADEX 10.8 mg by luteinizing hormone (LH).
This description comes directly from the study's public registry record.
Christine Fredericks · 1-888-600-8116 · christine.fredericks@tersera.com
Always discuss trial participation with your own doctor first.
| Genesis Cancer and Blood Institute | Hot Springs, Arkansas, United States | Recruiting |
| MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | Recruiting |
| Cancer Centers of Florida | Ocoee, Florida, United States | Recruiting |
| Summit Cancer Care | Savannah, Georgia, United States | Recruiting |
| NorthShore University HealthSystem - Evanston Hospital | Evanston, Illinois, United States | Recruiting |
| Duly Health and Care | Lisle, Illinois, United States | Recruiting |
| Orchard Healthcare Research | Skokie, Illinois, United States | Recruiting |
| Profound Research LLC at Michigan Hematology and Oncology Consultants | Royal Oak, Michigan, United States | Recruiting |
| St. Vincent Frontier Cancer Center (SVFCC) - Billings (Frontier Cancer Center and Blood Institute) | Billings, Montana, United States | Recruiting |
| San Juan Oncology Associates | Farmington, New Mexico, United States | Recruiting |
| Montefiore Medical Center | East Syracuse, New York, United States | Recruiting |
| The Blavatnik Family, Chelsea Medical Center at Mount Sinai | Mount Sinai, New York, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07310420